Incidence of major structural cardiac defects associated with increased nuchal translucency but normal karyotype

Ultrasound in Obstetrics and Gynecology

Volumn 18, Issue 6, 2001, Pages 610-614

  Ghi, T ^a   Huggon, I C ^a   Zosmer, N ^a   Nicolaides, K H ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Cardiac defects; First trimester; Nuchal translucency; Screening; Ultrasound

Indexed keywords

ARTICLE; CHROMOSOME; CONGENITAL HEART MALFORMATION; ECHOCARDIOGRAPHY; FETUS; FETUS ECHOGRAPHY; GESTATIONAL AGE; HUMAN; KARYOTYPE; MATERNAL DIABETES MELLITUS; PREGNANCY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL;

ECHOCARDIOGRAPHY; FEMALE; HEART DEFECTS, CONGENITAL; HUMANS; INCIDENCE; KARYOTYPING; NECK; PREGNANCY; ULTRASONOGRAPHY, PRENATAL;

EID: 0035685960     PISSN: 09607692     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0960-7692.2001.00584.x     Document Type: Article

References (23)

1. Fetal nuchal translucency: Ultrasound screening for chromosomal defects in first trimester of pregnancy
2. Fetal nuchal translucency thickness: Ultrasound screening for fetal trisomy in the first trimester of pregnancy
3. Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation
4. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation
5. Increased nuchal translucency in trisomy 21 fetuses: Relationship to narrowing of the aortic isthmus
6. Abnormalities of the heart and great arteries in first trimester chromosomally abnormal fetuses
7. Down's syndrome, cardiac anomalies and nuchal translucency. Fetal heart failure might link nuchal translucency and Down's syndrome
8. Abnormalities of the heart and great arteries in chromosomally normal fetuses with increased nuchal translucency thickness at 11-13 weeks of gestation
9. Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: Population based cohort study
10. Increased nuchal translucency at 10-14 weeks of gestation as a marker for major cardiac defects
11. Early diagnosis of major cardiac defects in chromosomally normal fetuses with increased nuchal translucency
12. Screening for fetal aneuploidies and fetal cardiac abnormalities by nuchal translucency thickness measurement at 10-14 weeks of gestation as part of routine antenatal care in an unselected population
13. Limitations of using first-trimester nuchal translucency measurement in routine screening for major congenital heart defects
14. Nuchal translucency measurement and pregnancy outcome in karyotypically normal fetuses
15. Prenatal detection of heart defects at the routine fetal examination at 18 weeks in a non-selected population
16. Fetal heart screening in low-risk pregnancies
17. Current and potential impact of fetal diagnosis on prevalence and spectrum of serious congenital heart disease at term in the UK
18. Nuchal translucency and congenital heart defects: Heart failure or not?
19. Presentation of congenital heart disease in infancy: Implications for routine examination
20. Recurrence risks in offspring of adults with major heart defects: Results from first cohort of British collaborative study
21. Incidence of congenital heart disease in fetuses of diabetic mothers: Retrospective study of 326 cases
22. Screening for chromosomal abnormalities at 10-14 weeks: The role of ductus venosus blood flow
23. Cardiac defects in chromosomally normal fetuses with abnormal ductus venosus blood flow at 10-14 weeks